title: [Acute orolingual angioedema associated to recombinant human tissue plasminogen activator treatment].
authors.affiliation: Unidad de Cuidados Neurocríticos, Hospital de Rehabilitación y Traumatología, Hospitales Universitarios Virgen del Rocío, Sevilla, España. Electronic address: gloriarivrub@gmail.com.
authors.forename: G
authors.initials: G
authors.lastname: Rivera-Rubiales
authors.affiliation: Unidad de Cuidados Neurocríticos, Hospital de Rehabilitación y Traumatología, Hospitales Universitarios Virgen del Rocío, Sevilla, España.
authors.forename: H
authors.initials: H
authors.lastname: Garcia-Delgado
authors.affiliation: Unidad de Cuidados Neurocríticos, Hospital de Rehabilitación y Traumatología, Hospitales Universitarios Virgen del Rocío, Sevilla, España.
authors.forename: J J
authors.initials: JJ
authors.lastname: Egea-Guerrero
mesh_terms: D000368:Aged; D000402:Airway Obstruction / Q000209:etiology* / Q000628:therapy; D000799:Angioedema / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004342:Drug Hypersensitivity / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000188:drug therapy; D010102:Oxygen Inhalation Therapy; D011994:Recombinant Proteins / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use
chemical_list: D018926:Anti-Allergic Agents; D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator; D004837:Epinephrine